SIX · GIVN.SW
Givaudan S.A.
CHF 3,916.00+CHF 2.00 (+0.05%)
Givaudan S.A.’s quoted price sits in the upper half of its reported 52-week range, 2.47% below the high.
Loading market information…
NYSE · IFF · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
International Flavors & Fragrances Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.06% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
International Flavors & Fragrances Inc.’s forward annual dividend is $1.60 per share, paid quarterly. The forward yield is 1.76% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
International Flavors & Fragrances Inc.’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of $0.81. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow International Flavors & Fragrances Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and plant-derived specialty food ingredients, offering items like flavor compounds, savory solutions, and inclusions. It also provides natural food protection solutions, including antioxidants and anti-microbials, for use in beverages, confectionery, and dairy items. 2. Scent: The Scent division creates fragrance compounds, encompassing luxurious fine fragrances (perfumes and colognes) and everyday consumer fragrances. It further supplies essential fragrance ingredients, both synthetic and natural, which are blended to formulate new scents. Additionally, this segment delivers cosmetic active ingredients, such as functional compounds, botanicals, and advanced delivery systems, designed to enhance customers' cosmetic and personal care product lines. 3. Health & Biosciences: This segment is dedicated to the research, development, and production of enzymes, food cultures, probiotics, and other specialized biological ingredients. 4. Pharma Solutions: This division is responsible for manufacturing and distributing cellulosic and seaweed-derived pharmaceutical excipients. IFF's diverse customer base primarily consists of manufacturers in sectors including perfumery, cosmetics, hair and personal care, soaps and detergents, cleaning products, dairy, meat and processed foods, beverages, snacks and savory items, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional foods, and producers of pharmaceutical excipients and oral care products. Established in 1833, International Flavors & Fragrances Inc. is headquartered in New York, New York.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| $2.76B+2.28% vs estimate |
| Q1 2025 | May 6, 2025 | $1.20+6.19% vs estimate | $2.84B+0.45% vs estimate |
|---|
| Q4 2024 | Feb 18, 2025 | $0.97+16.87% vs estimate | $2.77B+3.34% vs estimate |
|---|
| Q3 2024 | Nov 5, 2024 | $1.04-2.8% vs estimate | $2.93B+3.28% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
34 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 7 contributors · Median target $95.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CHF 3,916.00+CHF 2.00 (+0.05%)
Givaudan S.A.’s quoted price sits in the upper half of its reported 52-week range, 2.47% below the high.
€106.40+€0.65 (+0.61%)
dsm-firmenich AG’s quoted price sits in the upper half of its reported 52-week range, 3.14% below the high.
€91.76+€1.96 (+2.18%)
Symrise AG’s quoted price sits in the upper half of its reported 52-week range, 10.78% below the high.
$46.80+$0.75 (+1.62%)
McCormick & Company, Incorporated’s quoted price sits in the lower half of its reported 52-week range, 35.37% below the high.
£36.13+£0.02 (+0.06%)
Croda International Plc’s quoted price sits in the upper half of its reported 52-week range, 1.66% below the high.
$95.59+$1.34 (+1.42%)
Ingredion Incorporated’s quoted price sits in the lower half of its reported 52-week range, 22.59% below the high.
$131.53-$0.06 (-0.05%)
Sensient Technologies Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.25% below the high.
$170.40+$4.10 (+2.47%)
Balchem Corp’s quoted price sits in the upper half of its reported 52-week range, 7.34% below the high.
